CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Axovant Sciences Ltd.  (AXON)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

AXON's cumulative 12 Months Capital Expenditures Year on Year Growth

Capital Expenditures Growth for the trailing twelve months period, ending each quarter

Select the Comparisons : Select the Ratio:                        



Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2017)
12 Months Ending
(Jun 30 2017)
12 Months Ending
(Mar 31 2017)
12 Months Ending
(Dec 31 2016)
12 Months Ending
(Sep 30 2016)
Y / Y Capital Expenditures Growth (TTM) 45100 % 7073.33 % 0 % 1166.67 % -
Capital Expenditures Growth Overall Ranking # 2 # 5 # 1721 # 0 # 1731


Cumulative Capital Expenditures growth Comment
Axovant Sciences Ltd. saw improvement in Capital Expenditures growth trend, posting cumulative 12 months Capital Expenditures growth of 73537.5% year on year, to $ 6 millions if the fiscal year would have ended in Sep 30 2017.
Axovant Sciences Ltd.'s trailing twelve months Capital Expenditures growth was higher than company's average 13335% and higher than % growth in Jun 30 2017. And, Axovant Sciences Ltd. realized the fastest Capital Expenditures growth, in Biotechnology & Drugs industry.

Axovant Sciences Ltd. achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 1
Healthcare Sector # 1
Overall # 2

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
45100 %
13335 %
0 %
(Sep 30 2017)   (Mar 31 2017)


You need to upgrade your Flash Player


12 Months ending Capital Expenditures
(in millions $)
12 Months ending
(Sep 30 2017)
12 Months ending
(Jun 30 2017)
12 Months ending
(Mar 31 2017)
12 Months ending
(Dec 31 2016)
12 Months ending
(Sep 30 2016)
Cumulative Capital Expenditures TTM $ 3.62 $ 2.15 $ 0.01 $ 0.11 $ 0.01




Companies with similar Capital Expenditures for the twelve months ending period in Sep 30 2017 within Healthcare SectorSep 30 2017 TTM Capital ExpendituresY/Y Change %
Aimmune Therapeutics, Inc.$ 6.192 millions -15.66 %
Tesaro, Inc.$ 6.001 millions  166.00 %
Xencor Inc$ 5.923 millions  86.79 %
Nobilis Health Corp.$ 5.831 millions 0.00 %
Medicines Co$ 5.781 millions 0.00 %
Tivity Health, Inc.$ 5.588 millions -73.64 %
Horizon Pharma Plc$ 5.583 millions -68.37 %
Healthcare Services Group Inc$ 5.496 millions  11.46 %
K2m Group Holdings, Inc.$ 5.418 millions -69.96 %
Achaogen Inc$ 5.394 millions  889.72 %
National Research Corporation$ 5.353 millions  352.49 %
Medpace Holdings, Inc.$ 5.280 millions 0.00 %
Intellia Therapeutics, Inc.$ 5.209 millions  71.63 %
Fibrogen Inc$ 5.138 millions  263.11 %
Petmed Express Inc$ 5.095 millions -80.26 %
La Jolla Pharmaceutical Co$ 5.087 millions  227.35 %
Ardelyx, Inc.$ 5.085 millions  98.48 %
Mimedx Group, Inc.$ 5.069 millions -27.62 %
Accuray Inc$ 4.994 millions -36.15 %
Conformis Inc$ 4.986 millions -31.38 %
Coherus Biosciences, Inc.$ 4.964 millions -21.11 %
Teladoc, Inc.$ 4.958 millions  58.30 %
Blueprint Medicines Corp$ 4.950 millions -18.72 %
Neurocrine Biosciences Inc$ 4.910 millions  6.99 %
Kindred Biosciences, Inc.$ 4.868 millions  227.59 %
Acceleron Pharma Inc$ 4.773 millions  87.47 %
Five Prime Therapeutics Inc$ 4.720 millions  64.00 %
Infusystem Holdings, Inc$ 4.627 millions -41.07 %
Agios Pharmaceuticals Inc$ 4.569 millions -58.00 %
Repligen Corp$ 4.549 millions  12.74 %



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DLA's Profile

Stock Price

DLA's Financials

DLA's Expectations

Business Description

Fundamentals

Charts & Quotes

DLA's News

Suppliers

DLA's Competitors

Customers & Markets

Economic Indicators

DLA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com